Warning Letters

Novo
Manufacturing

FDA scrutinizes Novo on production issues at semaglutide plant

The FDA rebuked Novo Nordisk, the maker of Wegovy and Ozempic, following a March inspection of the company’s production site in Kalundborg, Denmark.
Joseph Keenan Oct 31, 2024 9:33am
FDA

FDA issues Form 483s to Japanese, Indian drugmakers

Sep 10, 2024 8:50am
FDA

EyePoint's Yutiq production lands in the FDA's crosshairs

Aug 27, 2024 4:07pm
FDA

FDA rebukes troubled Eugia production site with a warning letter

Aug 19, 2024 8:10am
FDA

CDMO Brassica blasted in 4-observation FDA warning letter

Jul 24, 2024 9:25am
FDA

FDA slams Dr. Reddy's plants in India with a pair of Form 483s

Jun 25, 2024 8:10am